check_circleStudy Completed

Contraception

Yaz Flex - DDI Ketoconaz and DRSP, in combi w EE and E2

Trial purpose

‘Please see attached Study Results Summary below.’

Key Participants Requirements

Sex

N/A

Age

18 - 45 Years
  • -

  • -

Trial summary

Enrollment Goal
53
Trial Dates
September 2012 - April 2013
Phase
Phase 1
Could I Receive a placebo
N/A
Products
YAZ (EE20/DRSP, BAY86-5300)
Accepts Healthy Volunteer
Yes

Where to participate

StatusInstitutionLocation
Completed
Berlin, 13353, Germany
Completed
Köln, 51063, Germany

Trial design

Open-label, cross-over, parallel group study to evaluate the effect of repeated oral administration of 200 mg ketoconazole (KTZ) twice daily on the steady-state pharmacokinetics of orally administered drospirenone (DRSP) in combination with ethinylestradiol (EE) or estradiol (E2) after repeated applications of DRSP/EE (containing 3 mg DRSP and 0.02 mg EE) or DRSP/E2 (containing 3 mg DRSP and 1.5 mg E2) in healthy young women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A